Niven M.
- Country
- The Netherlands
- Department
- Department of Medical Oncology
Research Overview
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- Evaluation of Pembrolizumab-Based Combination Therapies in Metastatic Castration-Resistant Prostate Cancer: A Phase Ib/II Clinical Trial
- Phase 3 Open-Label Comparison of Ifinatamab Deruxtecan and Docetaxel in Metastatic Castration-Resistant Prostate Cancer
Data & Insights
Has run more than one trial at 64 of 268 partner sites.
Specializations
Advanced Breast Cancer Treatment
The investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular focus on developing therapeutic strategies for locally recurrent inoperable and metastatic cases.
- Immunotherapy combinations with chemotherapy
- CDK4/6 inhibition approaches
- Endocrine therapy optimization
Their work extends to evaluating novel therapeutic combinations for patients with HER2-low expressing breast cancers.
High-Risk Breast Cancer Management
The investigator focuses on developing personalized treatment approaches for BRCA1-like breast cancer patients, with emphasis on neoadjuvant systemic treatments and innovative chemotherapy protocols.
- Alkylating chemotherapy intensification
- Stem cell rescue procedures
- Targeted therapy with PARP inhibitors
Their research includes optimization of treatment strategies for stage III HER2-negative breast cancer.
Supportive Cancer Care
The investigator conducts research in palliative care management for advanced cancer patients, with particular attention to managing treatment-related complications.
- Opioid-induced side effect management
- Pain control optimization
- Preventive care protocols
Their work includes developing strategies for symptom management in advanced cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.